Company Filing History:
1 out of 987 
1 out of 1,210 
Years Active: 2017
Title: Innovations in Immunotherapy: The Contributions of Vijayakumar Velu
Introduction
Vijayakumar Velu is an accomplished inventor based in Tucker, Georgia, known for his significant contributions to the field of immunotherapy. His innovative work focuses on methods for treating infections and tumors, particularly through the use of PD-1 antagonists. With one patent to his name, Velu's research has the potential to enhance immune responses in patients suffering from persistent infections and tumors.
Latest Patents
Vijayakumar Velu's patent, titled "Methods for the treatment of infections and tumors," discloses the use of PD-1 antagonists to reduce the expression or activity of PD-1 in subjects. This groundbreaking approach allows for the enhancement of immune responses specific to infectious agents or tumor cells. The patent outlines methods for treating subjects with infections and tumors by administering a therapeutically effective amount of activated T cells alongside PD-1 antagonists. Additionally, the patent includes methods for determining the efficacy of PD-1 antagonists by measuring the proliferation of memory B cells in samples from treated subjects.
Career Highlights
Throughout his career, Vijayakumar Velu has worked with prestigious institutions, including Emory University and Dana-Farber Cancer Institute. His research has contributed to the understanding of immune responses and the development of novel therapeutic strategies for combating infections and tumors. Velu's work exemplifies the intersection of innovative research and practical applications in medicine.
Collaborations
Vijayakumar Velu has collaborated with notable colleagues in the field, including Rafi Ahmed and Rama Rao Amara. These collaborations have further enriched his research and contributed to advancements in immunotherapy.
Conclusion
Vijayakumar Velu's innovative work in immunotherapy, particularly through his patent on PD-1 antagonists, showcases his commitment to improving treatment options for patients with infections and tumors. His contributions to the field highlight the importance of research and collaboration in advancing medical science.